Internal Medicine CME
31 - 42 of 42 results
- FREE
ScientiaCME Addressing unmet needs and updates in the pharmacotherapeutic management of alpha-1 antitrypsin deficiency (AATD) and its complications
Activity Description / Statement of Need:
In this online, self-learning activity:
Alpha 1-antitrypsin deficiency (AATD), characterized by misfolded and lower function of the serine protease inhibitor alpha-1 antitrypsin (AAT), is a genetic disorder resulting in the degradation of lung structures. Reduced levels of AAT result in overactivity of neutrophil elastase, which destroys connectivetissue within the lung and causes degradation of alveoli, reduced pulmonary elastic recoil, and airflow. Breakdown of the alveoli eventually manifest as chronic obstructive lung disease (COPD), and otherassociated complications include liver disease, which occurs in about ten percent of patients with AATD.The most common cause of death in patients with severe AATD is respiratory failure, which accounts for45 to 72% of deaths.
Target Audience:
The following HCPs: pulmonologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in pulmonology and internal medicine; and any other healthcare professionals with an interest in or who clinically encounter patients with AATD.
See full details chevron_right- Cost: Free
- Credit hours: 1
- CME credits awarded by: ScientiaCME
- Format: On-Demand Online
- Material last updated: 02/05/2023
- Expiration of CME credit: 02/05/2025
Cleveland Clinic 27th Annual Diabetes Therapeutics, Technology and Surgery
For over a quarter century, Cleveland Clinic has been at the forefront of continuing education regarding the treatment and management of diabetes. Its world class faculty has designed the 27th Annual Diabetes Therapeutics, Technology and Surgery to provide up-to-date reviews of strategies and research relevant to this disease and its complications. The goal of this activity is to increase practitioners’ competence and clinical performance in the management of type 1 and type 2 diabetes. A greater understanding of the disease and available treatment options will lead to better patient outcomes. Worth 8.5 AMA PRA Category I Credits™, this enduring material is designed for primary care physicians, endocrinologists, diabetes educators, nurses, nurse practitioners, physician assistants and dietitians, with NO POST TEST. Additionally, physicians can earn up to 8.5 ABIM MOC points for this activity.
See full details chevron_right- Cost: $175
- Credit hours: 8.5
- Format: On-Demand Online
- Material last updated: 7/11/23
- Expiration of CME credit: 7/10/25
- FREE
ScientiaCME Optimizing our management of lipodystrophy syndromes
- Cost: Free
- Credit hours: 1
- Format: On-Demand Online
- Material last updated: 02/14/2024
- Expiration of CME credit: 02/14/2026
- FREE
ScientiaCME A critical appraisal of present and emerging management approaches to moderate to severe plaque psoriasis in adults: going beyond skin-deep
- Cost: Free
- Credit hours: 1.25
- Format: On-Demand Online
- Material last updated: 06/07/2024
- Expiration of CME credit: 06/07/2026
- FREE
ScientiaCME Best practices and next directions in the management of chronic heart failure with reduced ejection fraction (HFrEF): getting to the heart of the matter
- Cost: Free
- Credit hours: 1
- Format: On-Demand Online
- Material last updated: 06/15/2024
- Expiration of CME credit: 06/15/2026
- FREE
ScientiaCME Tackling a sore subject: best practices in the identification and management of psoriatic arthritis (PsA)
- Cost: Free
- Credit hours: 1
- Format: On-Demand Online
- Material last updated: 06/22/2024
- Expiration of CME credit: 06/22/2026
- FREE
ScientiaCME Cholangiopathy management updates with an eye on the horizon: focus on primary biliary and primary sclerosing cholangitis
- Cost: Free
- Credit hours: 1
- Format: On-Demand Online
- Material last updated: 07/19/2024
- Expiration of CME credit: 07/19/2026
- FREE
ScientiaCME Cholangiopathy management updates with an eye on the horizon: focus on primary biliary cholangitis
- Cost: Free
- Credit hours: 1
- Format: On-Demand Online
- Material last updated: 07/19/2024
- Expiration of CME credit: 07/19/2026
- FREE
ScientiaCME The present and future state of care in hereditary angioedema (HAE)
In this online, self-learning activity:
Hereditary angioedema (HAE) is a rare, debilitating, and potentially life-threatening disease due to C1-inhibitor (C1-INH) deficiency with an estimated prevalence of 5,000 people in the U.S. and over 116,000 worldwide. HAE is characterized by recurrent edema, and the cutaneous attacks can be disabling, with the skin, gastrointestinal tract, and upper airways are most commonly affected. Patients are also under persistent risk of laryngeal swelling that may prove fatal if not treated in a timely manner. The disease is classified as: HAE with normal functional C1INH protein (previously known as type III HAE) or HAE due to a deficiency of C1INH protein, with the latter further distinguished either by deficiency in both concentrations and function of C1INH (type I) or by normal levels of dysfunctional C1INH (type II). Owing to its rarity and symptomatic overlap with other conditions, patients not uncommonly experience a diagnostic delay of 8 to 10 years, putting them at a higher risk of inappropriate treatment, morbidity, and mortality.
Target Audience:
See full details chevron_right
HCPs including: allergists, immunologists, emergency medicine specialists, and internists; physician assistants, nurse practitioners, and pharmacists specializing in immunology; and any other HCPs who have an interest in or otherwise clinically encounter patients with HAE.- Cost: Free
- Credit hours: .75
- Format: On-Demand Online
- Material last updated: 07/29/2024
- Expiration of CME credit: 07/29/2026
- FREE
ScientiaCME Safe and sound: empowering professionals with insights into the identification and management of alpha-mannosidosis
In this online, self-learning activity:
Alpha-mannosidosis (AM) is a rare recessive lysosomal storage disorder characterized by immune deficiency, facial and skeletal abnormalities, hearing impairment, and intellectual disability. It is caused by mutations in the MAN2B1 gene, leading to deficiency in alpha-mannosidase, a lysosomal enzyme involved in the oligosaccharide degradation pathway. While the exact prevalence of AM in the US is unknown, it has an estimated incidence of 1 in 500,000 live births worldwide. Laboratory indicators of AM often appear shortly after birth, followed by progression of clinical manifestations. While symptoms of AM vary considerably in individual presentations, three clinical subtypes have been identified (mild, moderate, and severe) and are used to guide disease prognosis and management. The current diagnostic algorithm for AM focuses on measuring alpha-mannosidase activity in leukocytes using colorimetry or fluorimetry. An alpha-mannosidase activity level of under 5% suggests AM, and a diagnosis is then confirmed with genetic sequencing.
See full details chevron_right- Cost: Free
- Credit hours: 1
- CME credits awarded by: ScientiaCME
- Format: On-Demand Online
- Material last updated: January 06, 2025
- Expiration of CME credit: January 06, 2027
- UNAVAILABLE
GIBLIB CME Plan
GIBLIB is an on-demand streaming medical education platform where physicians and advanced practice providers go to learn and earn CME through convenient, high-quality educational content created by trusted experts from the world’s top hospitals.
With this purchase, you get a 1-year subscription to GIBLIB and the following features:
- Earn unlimited AMA PRA Category 1 Credits™
- Full library access to thousands of videos across all specialties
- Personalized and curated video recommendations
- Cross-device viewing on web and iOS
- New content released and available every week
- Create custom playlists that you can personally curate
- Bookmark videos for later viewing
- Take notes on specific content and review for later
- View transcripts of all videos, available in multiple languages
- Credit hours: Unlimited
- Format: Videos, Audio, Podcasts, Transcripts (on every Video)
- UNAVAILABLE
Cleveland Clinic Interprofessional Approach to Liver Disease
The management of critically ill patients with liver disease requires the expertise of a variety of healthcare providers from multiple disciplines. Cleveland Clinic addresses their multifaceted educational needs with the Interprofessional Approach to Liver Disease. Physicians, nurses and physician assistants will benefit from the latest strategies and evidence based management guidance from an expert faculty. Worth 14 AMA PRA Category I Credits™, with ANCC and AAPA accreditation provided as well. This enduring material also qualifies for 14 ABIM MOC points, with NO POST TEST.
See full details chevron_right- Credit hours: 14
- Format: On Demand Online
- Material last updated: 10/15/22
- Expiration of CME credit: 10/14/24